Driehaus Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Driehaus Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-167,588	Closed	-$6.59M	–	467
2023 Q2	$6.59M	Sell	167,588 -366,230	-69%	-$12.9M	0.08%	260
2023 Q1	$13M	Sell	533,818 -248,904	-32%	-$5.45M	0.18%	181
2022 Q4	$16.8M	Buy	782,722 +31,232	+4%	+$667K	0.25%	138
2022 Q3	$13.5M	Sell	751,490 -364,911	-33%	-$4.79M	0.2%	152
2022 Q2	$10.7M	Buy	1,116,401 +271,587	+32%	+$3.41M	0.17%	188
2022 Q1	$14.2M	Sell	844,814 -16,227	-2%	-$240K	0.17%	177
2021 Q4	$14.4M	Sell	861,041 -71,391	-8%	-$1.17M	0.15%	195
2021 Q3	$15.1M	Buy	+932,432	New	+$10.1M	0.18%	175
2016 Q4	–	Sell	-35,306	Closed	-$1.63M	–	674
2016 Q3	$1.63M	Buy	35,306 +6,761	+24%	+$381K	0.06%	299
2016 Q2	$1.46M	Buy	+28,545	New	+$1.42M	0.05%	302

Driehaus Capital Management's ISEE Position: Q3 2023 in Review

Driehaus Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 167,588 shares — an estimated $6.59M sold.

Driehaus Capital Management first reported a position in ISEE in Q2 2016 and held it in 10 quarters. The position peaked at $16.8M in Q4 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Driehaus Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Driehaus Capital Management sold 167,588 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $6.59M.
Driehaus Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 10 quarters.
Driehaus Capital Management's IVERIC bio, Inc. Common Stock position peaked at $16.8M in Q4 2022.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Driehaus Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.